TetraLogic Pharma (TLOG) Misses Q4 EPS by 14c

TetraLogic Pharma (NASDAQ: TLOG) reported Q4 EPS of ($0.53), $0.14 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on TetraLogic Pharma (TLOG) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• Paramount Global (PARA) Tops Q2 EPS by 175c